RAND > About RAND > Our Staff > Dana P. Goldman

HomeGo to RAND HomeAbout RAND
Share

Staff Profiles

Photo of Dana P. Goldman

Dana P. Goldman

Santa Monica Office

Affiliated Adjunct Staff

Media Availability

This researcher is available for interviews. Show Details »

Education

Ph.D. in economics, Stanford University; B.A. in economics, Cornell University

Biography

Dana P. Goldman was the founding director of the Bing Center for Health Economics at RAND. Heis also the director of the RAND Roybal Center for Health Policy Simulation, which is designed to provide better estimates of the effects of health policy changes. His research interests combine applied microeconomics and medical issues, with a special interest in the role that medical technology and health insurance play in determining health-related outcomes.

Research Focus

Economics of chronic disease; health care reform; health care organization, economics, and finance; pharmaceutical regulation and innovation; pharmacy benefit design

Recent Projects

  • Roybal Center for Health Policy Simulation sponsored by National Institute of Aging, 2004-2009
  • Understanding How Cost-Sharing Affects Use of Specialty Drugs sponsored by Genentech, 2006-2007
  • Education, Self-Management, and Adherence sponsored by National Institute of Aging, 2003-2007
  • An Investigation of the Viatical Settlements Market sponsored by National Institute of Aging, 2003-2007
  • Public Policy and Pharmaceutical Innovation Around the World sponsored by Pfizer Incorporated, 2005-2007

Selected Publications

Darius Noshir Lakdawalla et al., "HIV Breakthroughs and Risky Sexual Behavior", Quarterly Journal of Economics, 121(3), 2006

D. Goldman et al., "Consequences of Health Trends and Medical Innovation for the Elderly of the Future", Health Affairs [Web exclusive], 2005

D. Goldman and J. Smith, "Socioeconomic Differences in the Adoption of New Medical Technologies", American Economic Review Papers and Proceedings, 95(2), 2005

D. P. Goldman et al., "Pharmacy Benefits and the Use of Drugs by the Chronically Ill", Journal of the American Medical Association, 291(19), 2004

E. Keeler et al., "Can Medical Savings Accounts for the Nonelderly Reduce Health Care Costs?", Journal of the American Medical Association, 275(21), 1996

Research Focus

Economics of chronic disease, health care reform, health care organization, economics, and finance, pharmaceutical regulation and innovation, pharmacy benefit design

Recent Projects

  • Prescription drug benefits
  • How new medical treatments affect the chronically ill

Selected Publications

"HIV Breakthroughs and Risky Sexual Behavior," Darius Noshir Lakdawalla et al., Quarterly Journal of Economics, Vol. 121, No. 3, Aug 2006

"Consequences of Health Trends and Medical Innovation for the Elderly of the Future," D. Goldman et al., Health Affairs [Web exclusive], Sept 2005

"Socioeconomic Differences in the Adoption of New Medical Technologies," D. Goldman and J. Smith, American Economic Review Papers and Proceedings, Vol. 95, No. 2, 2005

"Pharmacy Benefits and the Use of Drugs by the Chronically Ill," D. P. Goldman et al., Journal of the American Medical Association, Vol. 291, No. 19, May 2004

"Can Medical Savings Accounts for the Nonelderly Reduce Health Care Costs?" E. Keeler et al., Journal of the American Medical Association, Vol. 275, No. 21, 1996

Recent Media Appearances

Interviews: ABC; Bloomberg News; Boston Globe; CBS; CNN; The Economist; HealthDay.com; NBC; USA Today; Wall Street Journal

Commentary: Los Angeles Times; Press-Enterprise; United Press International

To arrange an interview:

Contact the RAND Office of Media Relations, (703) 413-1100, x5117 or (310) 451-6913, or send an email to media@rand.org.

Stay Informed Subscribe to RSS Feeds Search RAND Publications View Cart